Apple Tree Partners Iv, L.P. Stoke Therapeutics, Inc. (STOK) insider trading activity

Apple Tree Partners Iv, L.P. is > 10% Shareholder of Stoke Therapeutics, Inc.. Currently has a direct ownership of 0 shares of STOK, which is worth approximately $0. The most recent transaction as insider was on Jun 28, 2021, when has been sold 17,161,713 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Apple Tree Partners IV, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 28 2021	SELL Other acquisition or disposition	-	17,161,713 Reduced 100.0%	0 Common Stock
Nov 24 2020	BUY Open market or private purchase	$14,625,000 $39.0 p/Share	375,000 Added 2.14%	17,161,713 Common Stock

Also insider at

AKRO

Akero Therapeutics, Inc. Healthcare

> 10% Shareholder

ATP